ONCrg team is headed to the 31st SNO Annual Meeting!
This year’s theme, “Crossing the Translational Divide: From Neurons to Novel Therapies,” closely mirrors our commitment to evaluating breakthrough scientific data and translating it into actionable competitive intelligence for oncology innovators.
Our Ph.D. analysts look forward to tracking key clinical updates across gliomas, including emerging targeted therapies, cell therapies, and novel treatment combinations to keep our biopharma partners ahead of evolving landscape dynamics.
Are you or your team attending SNO 2026? Let’s connect in Philly to discuss the latest data and explore how ONCrg’s landscape, surveillance, and conference intelligence can support your neuro-oncology strategy.
#SNO2026 #Gliomas #Oncology #CompetitiveIntelligence #ClinicalData
- clinical data
- Oncology
- Competitive Insights
- SNO 2026
- Gliomas
- +2